©The Author(s) 2025.
World J Gastrointest Surg. Aug 27, 2025; 17(8): 104568
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.104568
Published online Aug 27, 2025. doi: 10.4240/wjgs.v17.i8.104568
Table 2 Treatment administration details
| Treatment component | n (%) |
| TACE procedures | 3 (1-6) |
| Chemotherapeutic agents | |
| Doxorubicin | 70 (93.3) |
| Cisplatin | 65 (86.7) |
| Embolic agents | |
| Lipiodol | 72 (96) |
| Gelatin sponge particles | 60 (80) |
| Targeted therapy agents | |
| Bevacizumab | 40 (53.3) |
| Cetuximab | 25 (33.3) |
| Panitumumab | 10 (13.3) |
- Citation: Liu JY, Liang ZH, Liu JL, Li L, Cui B, Li TG. Clinical observation of combined transarterial chemoembolization and targeted therapy in postoperative recurrent colorectal cancer with liver metastasis. World J Gastrointest Surg 2025; 17(8): 104568
- URL: https://www.wjgnet.com/1948-9366/full/v17/i8/104568.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i8.104568